Who
Adam Leo Stone
Other role
Company insider
Files Form 4 as: Chief Executive Officer, Freenome; Director, Immatics; Director, Solid Biosciences; 10% owner, Adagio Medical Holdings; Chief Executive Officer, ARYA Sciences Acquisition Corp IV; Interim CEO, LianBio; Chief Executive Officer, ARYA Sciences Acquisition Corp V; Chief Executive Officer, Nautilus Biotechnology.
In numbers
- Trades disclosed
- 31
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 9
- Companies where not an officer
- 3
- First trade
- 25 Jul 2018
- Last trade
- 20 Jul 2026
- Last filed
- 22 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Jul 2026filed 22 Jul 2026 | FRNM FreenomeDiagnostics & Labs | SEC FORM 4 Code C | —2,066,250 | filing |
| 20 Jul 2026filed 22 Jul 2026 | FRNM Freenomeoption or derivative · Diagnostics & Labs | SEC FORM 4 Code C | —2,066,250 | filing |
| 20 Jul 2026filed 22 Jul 2026 | FRNM Freenomeoption or derivative · Diagnostics & Labs | SEC FORM 4 Code C | —2,066,250 | filing |
| 20 Jul 2026filed 22 Jul 2026 | FRNM FreenomeDiagnostics & Labs | SEC FORM 4 Code C | —2,066,250 | filing |
| 16 Jun 2026filed 18 Jun 2026 | IMTX Immaticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —48,000 at $0.00 | filing |
| 16 Jun 2026filed 18 Jun 2026 | IMTX Immaticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —48,000 at $0.00 | filing |
| 10 Jun 2026filed 11 Jun 2026 | SLDB Solid Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —77,500 at $0.00 | filing |
| 10 Jun 2026filed 11 Jun 2026 | SLDB Solid Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —77,500 at $0.00 | filing |
| 12 Jun 2025filed 13 Jun 2025 | SLDB Solid Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —77,500 at $0.00 | filing |
| 27 Sep 2024filed 1 Oct 2024 | ADGM Adagio Medical HoldingsMedical Devices | SEC FORM 4 Code J | —3,501,600 | filing |
| 31 Jul 2024filed 31 Jul 2024 | ARYA Sciences Acquisition Corp IVoption or derivative | SEC FORM 4 Code D | —1,000,000 | filing |
| 31 Jul 2024filed 31 Jul 2024 | ARYA Sciences Acquisition Corp IVoption or derivative | SEC FORM 4 Code D | —2,647,500 | filing |
| 31 Jul 2024filed 31 Jul 2024 | ARYA Sciences Acquisition Corp IV | SEC FORM 4 Code D | —499,000 | filing |
| 13 Jun 2024filed 13 Jun 2024 | FRNM FreenomeDiagnostics & Labs | SEC FORM 4 Code A | $2.9M286,250 at $10.00 | filing |
| 11 Jun 2024filed 19 Nov 2024 | SLDB Solid Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,400 at $0.00 | filing |
| 15 Feb 2024filed 20 Feb 2024 | LianBiooption or derivative | SEC FORM 4 Code M | —36,300 at $0.00 | filing |
| 15 Feb 2024filed 20 Feb 2024 | LianBio | SEC FORM 4 Code M | $91K36,300 at $2.52 | filing |
| 15 Feb 2024filed 20 Feb 2024 | LianBio | SEC FORM 4 Code F | $91K19,218 at $4.76 | filing |
| 21 Jun 2023filed 23 Jun 2023 | LianBiooption or derivative | SEC FORM 4 Code A | —36,300 at $0.00 | filing |
| 6 Jun 2023filed 8 Jun 2023 | SLDB Solid Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,650 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.